ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Peng Wang
Matched on ORCID iD 0000-0003-4666-9706; OpenAlex author ID A5100634561. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers
Papers 9
- The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies. Co-author DOI 10.1007/s00394-023-03302-w↗
- Coffee and Risk of Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian Randomization Analyses. First author DOI 10.3390/nu16213723↗
- A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12935-023-03107-1↗
- Association between plasma 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis Co-author DOI 10.21203/rs.3.rs-1968094/v1↗
- Coffee consumption and risk of pancreatic cancer: a systematic review and dose-response meta-analysis. Co-author DOI 10.1080/09637486.2018.1551337↗
- Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated? Last author DOI 10.1177/1534735418794884↗
- XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatme… Co-author DOI 10.1080/19420862.2016.1160989↗
- Radiation promotes epithelial-to-mesenchymal transition and invasion of pancreatic cancer cell by activating carcinoma-associated fibroblasts. Co-author PMID 27822411↗
- [Analysis of the changes of blood glucose after radiotherapy in pancreatic cancer patients associated with diabetes mellitus and their related factors]. Co-author PMID 25877316↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tiandong Li · 5 shared papers, 2019–2024 · strength 0.88
- Paper Coffee and Risk of Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian Randomization Analyses. DOI 10.3390/nu16213723↗
- Paper The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of… DOI 10.1007/s00394-023-03302-w↗
- Paper A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma. DOI 10.1186/s12935-023-03107-1↗
- Hua Ye · 4 shared papers, 2022–2024 · strength 0.78
- Paper Coffee and Risk of Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian Randomization Analyses. DOI 10.3390/nu16213723↗
- Paper The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of… DOI 10.1007/s00394-023-03302-w↗
- Paper A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma. DOI 10.1186/s12935-023-03107-1↗
- Yajing Shen · 3 shared papers, 2022–2024 · strength 0.55
- Paper The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of… DOI 10.1007/s00394-023-03302-w↗
- Paper A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma. DOI 10.1186/s12935-023-03107-1↗
- Paper Association between plasma 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis DOI 10.21203/rs.3.rs-1968094/v1↗
- Yin Lu · 1 shared paper, 2024 · strength 0.23
- Chao Qu · 2 shared papers, 2016–2018 · strength 0.18
- Zhiqiang Meng · 2 shared papers, 2016–2018 · strength 0.18
- Hua Ye · 1 shared paper, 2019 · strength 0.10
- Yong Li · 1 shared paper, 2015 · strength 0.06
- Li Zhang · 1 shared paper, 2015 · strength 0.06
- Zhouyu Ning · 1 shared paper, 2016 · strength 0.06
- Doudou Li · 1 shared paper, 2016 · strength 0.06
- Liping Zhuang · 1 shared paper, 2016 · strength 0.06
- Lianyu Chen · 1 shared paper, 2016 · strength 0.06
- Juergen M. Schanzer · 1 shared paper, 2016 · strength 0.05
- Christian Klein · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.